thedailyupside.com·Apr 27, 2026
Recent executive orders in the U.S. aimed at reclassifying medical marijuana and promoting psychedelic research have led to a temporary boost in thematic ETFs focused on cannabis and psilocybin, although the long-term effects remain uncertain as further regulatory details are awaited.
Recent executive orders have reclassified medical marijuana and prioritized research into psychedelics, initially boosting thematic ETFs like AdvisorShares Psychedelics ETF (PSIL) and cannabis ETFs such as MJ and CNBS. While these developments signal potential policy breakthroughs, the market's response has been cautious, highlighting the importance of monitoring regulatory changes and their impact on thematic ETF performance for informed investment decisions.